FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130359513> ?p ?o ?g. }

• W2130359513 abstract "Medication regimens for asthma are particularly vulnerable to adherence problems because of the requirement for long-term use and periods of symptom remission experienced by patients. Pharmacists are suited to impact medication adherence given their training, skills, and frequent contact with patients. The Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS) trial involves an intervention leveraging mobile health (mHealth) technology to support community pharmacy practice with the hypothesis of improved medication adherence in asthma. This study is a pragmatic pharmacy-based, cluster, randomized controlled trial with 12 months of intervention delivery and follow-up. Pharmacies (the clusters) will be randomized at a 1:1 ratio to provide intervention or usual care. The EmPhAsIS intervention consists of patient asthma education, short message service (SMS)-based monthly assessment of adherence, and follow-up of non-adherent individuals by community pharmacists. There are no inclusion or exclusion criteria for pharmacies. Patients are eligible if they: are 14 years of age or older, fill a prescription for inhaled corticosteroid (either monotherapy or in a combination inhaler with long-acting beta-agonists), have been diagnosed with asthma, possess a mobile phone with SMS capabilities, and have no communication difficulties such as inability to communicate in English, or significant impairment in vision, hearing, or speech. The primary outcome is adherence to inhaled corticosteroids ascertained by the medication possession ratio, the ratio of the days of medication supplied to days in a given time interval. This study will also evaluate secondary outcomes including: asthma control, asthma-related quality of life, asthma-related hospital admissions, and use of reliever medications during the follow-up period. A nested economic evaluation using a probabilistic decision-analytic model will be used to perform a cost-effectiveness analysis from the societal perspective of the intervention compared with usual care over a 10-year time horizon. Considering the prevalence of asthma, the extent of the non-adherence problem in this disease, and the availability of effective treatments, there is a tremendous potential to reduce the burden of asthma through improving adherence. This is the first study of an intervention based on mobile communication technology involving community pharmacists in asthma management. ClinicalTrials.gov identifier: NCT02170883 ; date of registration: 19 June 2014." @default.
• W2130359513 created "2016-06-24" @default.
• W2130359513 creator A5003715359 @default.
• W2130359513 creator A5017063873 @default.
• W2130359513 creator A5028772059 @default.
• W2130359513 creator A5037720506 @default.
• W2130359513 creator A5054105827 @default.
• W2130359513 creator A5060734842 @default.
• W2130359513 creator A5071876761 @default.
• W2130359513 creator A5073136103 @default.
• W2130359513 creator A5081943189 @default.
• W2130359513 date "2014-12-01" @default.
• W2130359513 modified "2023-09-26" @default.
• W2130359513 title "Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial" @default.
• W2130359513 cites W153364916 @default.
• W2130359513 cites W1683228896 @default.
• W2130359513 cites W1791960638 @default.
• W2130359513 cites W1973435903 @default.
• W2130359513 cites W1974042832 @default.
• W2130359513 cites W1977761895 @default.
• W2130359513 cites W1982680448 @default.
• W2130359513 cites W1990760674 @default.
• W2130359513 cites W1993769910 @default.
• W2130359513 cites W1994364818 @default.
• W2130359513 cites W2000521866 @default.
• W2130359513 cites W2004128497 @default.
• W2130359513 cites W2009200551 @default.
• W2130359513 cites W2011212850 @default.
• W2130359513 cites W2022378126 @default.
• W2130359513 cites W2022441342 @default.
• W2130359513 cites W2030196491 @default.
• W2130359513 cites W2043990114 @default.
• W2130359513 cites W2047673912 @default.
• W2130359513 cites W2052843612 @default.
• W2130359513 cites W2053237380 @default.
• W2130359513 cites W2057630808 @default.
• W2130359513 cites W2060732058 @default.
• W2130359513 cites W2062346210 @default.
• W2130359513 cites W2062940257 @default.
• W2130359513 cites W2063904763 @default.
• W2130359513 cites W2065633361 @default.
• W2130359513 cites W2070763554 @default.
• W2130359513 cites W2078078890 @default.
• W2130359513 cites W2080985256 @default.
• W2130359513 cites W2087196444 @default.
• W2130359513 cites W2091405674 @default.
• W2130359513 cites W2101212412 @default.
• W2130359513 cites W2101864423 @default.
• W2130359513 cites W2105665234 @default.
• W2130359513 cites W2106051200 @default.
• W2130359513 cites W2107219724 @default.
• W2130359513 cites W2110143000 @default.
• W2130359513 cites W2113710787 @default.
• W2130359513 cites W2116350670 @default.
• W2130359513 cites W2127212431 @default.
• W2130359513 cites W2131458953 @default.
• W2130359513 cites W2136199835 @default.
• W2130359513 cites W2137275746 @default.
• W2130359513 cites W2139159843 @default.
• W2130359513 cites W2142653918 @default.
• W2130359513 cites W2144504916 @default.
• W2130359513 cites W2145338500 @default.
• W2130359513 cites W2148958761 @default.
• W2130359513 cites W2155830934 @default.
• W2130359513 cites W2157029647 @default.
• W2130359513 cites W2157366410 @default.
• W2130359513 cites W2162494048 @default.
• W2130359513 cites W2163870114 @default.
• W2130359513 cites W2616424562 @default.
• W2130359513 cites W4231223325 @default.
• W2130359513 cites W4233954896 @default.
• W2130359513 cites W60542319 @default.
• W2130359513 doi "https://doi.org/10.1186/1745-6215-15-488" @default.
• W2130359513 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4301403" @default.
• W2130359513 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25494702" @default.
• W2130359513 hasPublicationYear "2014" @default.
• W2130359513 type Work @default.
• W2130359513 sameAs 2130359513 @default.
• W2130359513 citedByCount "14" @default.
• W2130359513 countsByYear W21303595132015 @default.
• W2130359513 countsByYear W21303595132016 @default.
• W2130359513 countsByYear W21303595132017 @default.
• W2130359513 countsByYear W21303595132018 @default.
• W2130359513 countsByYear W21303595132019 @default.
• W2130359513 countsByYear W21303595132023 @default.
• W2130359513 crossrefType "journal-article" @default.
• W2130359513 hasAuthorship W2130359513A5003715359 @default.
• W2130359513 hasAuthorship W2130359513A5017063873 @default.
• W2130359513 hasAuthorship W2130359513A5028772059 @default.
• W2130359513 hasAuthorship W2130359513A5037720506 @default.
• W2130359513 hasAuthorship W2130359513A5054105827 @default.
• W2130359513 hasAuthorship W2130359513A5060734842 @default.
• W2130359513 hasAuthorship W2130359513A5071876761 @default.
• W2130359513 hasAuthorship W2130359513A5073136103 @default.
• W2130359513 hasAuthorship W2130359513A5081943189 @default.
• W2130359513 hasBestOaLocation W21303595131 @default.
• W2130359513 hasConcept C104863432 @default.
• W2130359513 hasConcept C126322002 @default.
• W2130359513 hasConcept C159110408 @default.
• W2130359513 hasConcept C168563851 @default.

• next